Trade Soleno Therapeutics Inc - SLNO CFD

Add to favourite

49.24

0.47%

0.17

Low: 48.4

High: 49.51

Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

Summary
Historical Data

Trading сonditions

Spread

0.17

Long position overnight fee

-0.023374%

Short position overnight fee

0.001151%

Overnight fee time

21:00 (UTC)

Min traded quantity

0.1

Currency

USD

Margin

5.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	49.01
Open	49.32
1-Year Change	-0.14%
Day's Range	48.4 - 49.51

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Mar 13, 2025	49.01	3.78	8.36%	45.23	49.99	45.23
Mar 12, 2025	46.63	1.26	2.78%	45.37	46.93	44.73
Mar 11, 2025	44.69	1.40	3.23%	43.29	44.96	42.85
Mar 10, 2025	43.61	-0.36	-0.82%	43.97	45.18	43.38
Mar 7, 2025	44.75	0.80	1.82%	43.95	45.67	43.61
Mar 6, 2025	44.90	1.36	3.12%	43.54	45.46	43.54
Mar 5, 2025	44.96	0.61	1.38%	44.35	45.70	43.37
Mar 4, 2025	44.39	0.34	0.77%	44.05	45.63	43.27
Mar 3, 2025	45.75	-3.10	-6.35%	48.85	49.35	44.91
Feb 28, 2025	48.75	4.60	10.42%	44.15	49.42	43.15
Feb 27, 2025	44.86	-0.19	-0.42%	45.05	46.10	44.69
Feb 26, 2025	45.04	1.13	2.57%	43.91	46.86	43.91
Feb 25, 2025	44.83	0.38	0.85%	44.45	45.07	42.97
Feb 24, 2025	44.93	-1.08	-2.35%	46.01	46.30	43.73
Feb 21, 2025	46.04	-1.94	-4.04%	47.98	47.98	46.01
Feb 20, 2025	47.32	0.19	0.40%	47.13	47.73	46.11
Feb 19, 2025	47.32	-0.23	-0.48%	47.55	48.07	47.08
Feb 18, 2025	47.97	-1.15	-2.34%	49.12	50.67	47.89
Feb 14, 2025	49.04	-1.00	-2.00%	50.04	52.04	48.24
Feb 13, 2025	51.22	1.39	2.79%	49.83	51.27	49.83

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Soleno Therapeutics Inc

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is being evaluated in a Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics has collaboration with Vanderbilt University to discover and develop next generation K(ATP) channel activators for the treatment of rare diseases. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.